High-spatial-resolution lower extremity MR angiography at 3.0 T: Contrast agent dose comparison study

Radiology

Volumn 248, Issue 2, 2008, Pages 680-692

  Habibi, Reza ^a   Krishnam, Mayil S ^a   Lohan, Derek G ^a   Barkhordarian, Fatemeh ^a   Jalili, Mehdi ^a   Saleh, Roya S ^a   Ruehm, Stefan G ^a   Finn, J Paul ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE; CONTRAST MEDIUM;

ADULT; ARTERY OCCLUSION; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DOSE RESPONSE; FEMALE; HUMAN; IMAGE QUALITY; LEG; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; PRIORITY JOURNAL; ARTIFACT; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; METHODOLOGY; MIDDLE AGED; PERIPHERAL VASCULAR DISEASE; RETROSPECTIVE STUDY; VASCULARIZATION;

ARTIFACTS; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LOWER EXTREMITY; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; RETROSPECTIVE STUDIES;

EID: 49049116369     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2482071505     Document Type: Article

References (37)

1. Waugh JR, Sacharias N. Arteriographic complications in the DSA era. Radiology 1992;182:243-246.
2. Steffens JC, Schafer FK, Oberscheid B, et al. Bolus-chasing contrast-enhanced 3D MRA of the lower extremity: comparison with intraarterial DSA. Acta Radiol 2003;44:185-192.
3. Leiner T. Magnetic resonance angiography of abdominal and lower extremity vasculature. Top Magn Reson Imaging 2005;16:21-66.
4. Goyen M, Debatin JF, Ruehm SG. Peripheral magnetic resonance angiography. Top Magn Reson Imaging 2001;12:327-335.
5. Sueyoshi E, Sakamoto I, Matsuoka Y, et al. Aortoiliac and lower extremity arteries: comparison of three-dimensional dynamic contrast-enhanced subtraction MR angiography and conventional angiography. Radiology 1999;210:683-688.
6. Prince MR, Arnoldus C, Frisoli JK. Nephrotoxicity of high-dose gadolinium compared with iodinated contrast. J Magn Reson Imaging 1996;6:162-166.
7. Rieger J, Sitter T, Toepfer M, Linsenmaier U, Pfeifer KJ, Schiffl H. Gadolinium as an alternative contrast agent for diagnostic and interventional angiographic procedures in patients with impaired renal function. Nephrol Dial Transplant 2002;17:824-828.
8. Townsend RR, Cohen DL, Katholi R, et al. Safety of intravenous gadolinium (Gd-BOPTA) infusion in patients with renal insufficiency. Am J Kidney Dis 2000;36:1207-1212.
9. Tombach B, Bremer C, Reimer P, et al. Renal tolerance of a neutral gadolinium chelate (gadobutrol) in patients with chronic renal failure: results of a randomized study. Radiology 2001;218:651-657.
10. Sadowski EA, Bennett LK, Chan MR, et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 2007;243:148-157.
11. Broome DR, Girguis MS, Baron PW, Cottrell AC, Kjellin I, Kirk GA. Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. AJR Am J Roentgenol 2007;188:586-592.
12. Deo A, Fogel M, Cowper SE. Nephrogenic systemic fibrosis: a population study examining the relationship of disease development to gadolinium exposure. Clin J Am Soc Nephrol 2007;2:264-267.
13. Ersoy H, Zhang H, Prince MR. Peripheral MR angiography. J Cardiovasc Magn Reson 2006;8:517-528.
14. Boos M, Lentschig M, Scheffler K, Bongartz GM, Steinbrich W. Contrast-enhanced magnetic resonance angiography of peripheral vessels: different contrast agent applications and sequence strategies - a review. Invest Radiol 1998;33:538-546.
15. Rinck PA, Muller RN. Field strength and dose dependence of contrast enhancement by gadolinium-based MR contrast agents. Eur Radiol 1999;9:998-1004.
16. Morasch MD, Collins J, Pereles FS, et al. Lower extremity stepping-table magnetic resonance angiography with multilevel contrast timing and segmented contrast infusion. J Vasc Surg 2003;37:62-71.
17. Pereles FS, Collins JD, Carr JC, et al. Accuracy of stepping-table lower extremity MR angiography with dual-level bolus timing and separate calf acquisition: hybrid peripheral MR angiography. Radiology 2006;240:283-290.
18. Palmgren J. Analysis of longitudinal data [book review]. Stat Med 1998;15:1231-1232.
19. Landis JR, Koch GG. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 1977;33:363-374.
20. Kruskal WH, Wallis WA. Use of ranks in one-criterion variance analysis. J Am Stat Assoc 1952;47:583-621.
21. Perazella MA, Rodby RA. Gadolinium-induced nephrogenic systemic fibrosis in patients with kidney disease. Am J Med 2007;120:561-562.
22. Hedley AJ, Molan MP, Hare DL, Anavekar NS, Ierino FL. Nephrogenic systemic fibrosis associated with gadolinium-containing contrast media administration in patients with reduced glomerular filtration rate. Australas Radiol 2007;51:300.
23. Thomsen HS, Morcos SK. Nephrogenic systemic fibrosis and nonionic linear chelates. AJR Am J Roentgenol 2007;188:W580.
24. Campeau NG, Huston J 3rd, Bernstein MA, Lin C, Gibbs GF. Magnetic resonance angiography at 3.0 Tesla: initial clinical experience. Top Magn Reson Imaging 2001;12:183-204.
25. Willinek WA, Born M, Simon B, et al. Time-of-flight MR angiography: comparison of 3.0-T imaging and 1.5-T imaging - initial experience. Radiology 2003;229:913-920.
26. Nael K, Ruehm SG, Michaely HJ, et al. Multistation whole-body high-spatial-resolution MR angiography using a 32-channel MR system. AJR Am J Roentgenol 2007;188:529-539.
27. Kramer H, Michaely HJ, Reiser MF, Schoenberg SO. Peripheral magnetic resonance angiography at 3.0 T. Top Magn Reson Imaging 2007;18:135-138.
28. Nael K, Ruehm SG, Michaely HJ, et al. High spatial-resolution CE-MRA of the carotid circulation with parallel imaging: comparison of image quality between 2 different acceleration factors at 3.0 Tesla. Invest Radiol 2006;41:391-399.
29. Kramer H, Michaely HJ, Matschl V, Schmitt P, Reiser MF, Schoenberg SO. High-resolution magnetic resonance angiography of the lower extremities with a dedicated 36-element matrix coil at 3 Tesla. Invest Radiol 2007;42:477-483.
30. Leiner T, de Vries M, Hoogeveen R, Vasbinder GB, Lemaire E, van Engelshoven JM. Contrast-enhanced peripheral MR angiography at 3.0 Tesla: initial experience with a whole-body scanner in healthy volunteers. J Magn Reson Imaging 2003;17:609-614.
31. Krause U, Kroencke T, Spielhaupter E, et al. Contrast-enhanced magnetic resonance angiography of the lower extremities: standard-dose vs. high-dose gadodiamide injection. J Magn Reson Imaging 2005;21:449-454.
32. Rofsky NM, Johnson G, Adelman MA, Rosen RJ, Krinsky GA, Weinreb JC. Peripheral vascular disease evaluated with reduced-dose gadolinium-enhanced MR angiography. Radiology 1997;205:163-169.
33. Meaney JF, Ridgway JP, Chakraverty S, et al. Stepping-table gadolinium-enhanced digital subtraction MR angiography of the aorta and lower extremity arteries: preliminary experience. Radiology 1999;211:59-67.
34. Ho VB, Choyke PL, Foo TK, et al. Automated bolus chase peripheral MR angiography: initial practical experiences and future directions of this work-in-progress. J Magn Reson Imaging 1999;10:376-388.
35. Zhang HL, Ho BY, Chao M, et al. Decreased venous contamination on 3D gadolinium-enhanced bolus chase peripheral MR angiography using thigh compression. AJR Am J Roentgenol 2004;183:1041-1047.
36. Lenhart M, Djavidani B, Volk M, et al. Contrast medium-enhanced MR angiography of the pelvic and leg vessels with an automated table-feed technique [in German]. Rofo 1999;171:442-449.
37. Brillet PY, Vayssairat M, Tassart M, et al. Gadolinium-enhanced MR angiography as first-line preoperative imaging in high-risk patients with lower limb ischemia. J Vasc Interv Radiol 2003;14:1139-1145.